177 related articles for article (PubMed ID: 1695006)
1. Interleukin 1 receptor blockade attenuates the host inflammatory response.
Gershenwald JE; Fong YM; Fahey TJ; Calvano SE; Chizzonite R; Kilian PL; Lowry SF; Moldawer LL
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4966-70. PubMed ID: 1695006
[TBL] [Abstract][Full Text] [Related]
2. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6.
Oldenburg HS; Rogy MA; Lazarus DD; Van Zee KJ; Keeler BP; Chizzonite RA; Lowry SF; Moldawer LL
Eur J Immunol; 1993 Aug; 23(8):1889-94. PubMed ID: 8344351
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.
Oldenburg HS; Pruitt JH; Lazarus DD; Rogy MA; Chizzonite R; Lowry SF; Moldawer LL
Cytokine; 1995 Aug; 7(6):510-6. PubMed ID: 8580366
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6, but not ciliary neurotrophic factor or leukaemia inhibitory factor, is responsible for the acute phase response to turpentine-induced myositis.
Kaibara A; Espat NJ; Auffenberg T; Abouhamze AS; Martin D; Kalra S; Moldawer LL
Cytokine; 1998 Jun; 10(6):452-6. PubMed ID: 9632532
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra.
Josephs MD; Solorzano CC; Taylor M; Rosenberg JJ; Topping D; Abouhamze A; Mackay SL; Hirsch E; Hirsh D; Labow M; Moldawer LL
Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R824-30. PubMed ID: 10749768
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 and tumor necrosis factor α blockade treatment of experimental polymyositis in mice.
Sugihara T; Okiyama N; Watanabe N; Miyasaka N; Kohsaka H
Arthritis Rheum; 2012 Aug; 64(8):2655-62. PubMed ID: 22392010
[TBL] [Abstract][Full Text] [Related]
8. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
9. Role of several mediators of inflammation on the mouse hypothalamo-pituitary-adrenal axis response during acute endotoxemia.
Hadid R; Spinedi E; Chautard T; Giacomini M; Gaillard RC
Neuroimmunomodulation; 1999; 6(5):336-43. PubMed ID: 10474052
[TBL] [Abstract][Full Text] [Related]
10. Defective inflammatory response in interleukin 6-deficient mice.
Fattori E; Cappelletti M; Costa P; Sellitto C; Cantoni L; Carelli M; Faggioni R; Fantuzzi G; Ghezzi P; Poli V
J Exp Med; 1994 Oct; 180(4):1243-50. PubMed ID: 7931061
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines.
Bleau AM; Levitchi MC; Maurice H; du Souich P
Br J Pharmacol; 2000 Aug; 130(8):1777-84. PubMed ID: 10952665
[TBL] [Abstract][Full Text] [Related]
12. The roles of IL-1, IL-6, and TNFalpha in the feeding responses to endotoxin and influenza virus infection in mice.
Swiergiel AH; Dunn AJ
Brain Behav Immun; 1999 Sep; 13(3):252-65. PubMed ID: 10469526
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
14. IL-1 type I receptor mediates acute phase response to turpentine, but not lipopolysaccharide, in mice.
Leon LR; Conn CA; Glaccum M; Kluger MJ
Am J Physiol; 1996 Dec; 271(6 Pt 2):R1668-75. PubMed ID: 8997368
[TBL] [Abstract][Full Text] [Related]
15. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
[TBL] [Abstract][Full Text] [Related]
16. The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice.
Fantuzzi G; Dinarello CA
J Leukoc Biol; 1996 Apr; 59(4):489-93. PubMed ID: 8613694
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice.
Turnbull AV; Prehar S; Kennedy AR; Little RA; Hopkins SJ
Endocrinology; 2003 May; 144(5):1894-906. PubMed ID: 12697697
[TBL] [Abstract][Full Text] [Related]
18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
19. Cytokine modulation of liver annexin 1 expression during experimental endotoxemia.
de Coupade C; Ajuebor MN; Russo-Marie F; Perretti M; Solito E
Am J Pathol; 2001 Oct; 159(4):1435-43. PubMed ID: 11583971
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta peptide induced inflammatory reaction is mediated by the cytokines tumor necrosis factor and interleukin-1.
Sutton ET; Thomas T; Bryant MW; Landon CS; Newton CA; Rhodin JA
J Submicrosc Cytol Pathol; 1999 Jul; 31(3):313-23. PubMed ID: 10626000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
